PARR, THOMAS R.,MOECK, GREGORY,ETIENNE, PIERRE,LEHOUX, DARIO
申请号：
CA2736860
公开号：
CA2736860C
申请日:
2009.08.29
申请国别(地区):
CA
年份:
2020
代理人:
摘要：
Glycopeptide antibiotics, such as oritavancin, demonstrate significantactivity against a wide range ofbacteria. Methods for the treatment, prophylaxis and prevention of bacterialinfection and disease inanimals, including humans, using a single dose of oritavancin over the courseof therapy, are described.Also provided are uses of single intravenous doses comprising oritavancin forcomplete treatment ofcomplicated skin and skin structure infection in a subject.
